Evidence map›Paper›PMID 30386531›Full record

ReviewJournal of cardiovascular and thoracic research2018

A systematic review on the cardiovascular pharmacology of

Fataneh Hashem-Dabaghian, Mojtaba Ziaee, Samad Ghaffari, Farzaneh Nabati, Saeed Kianbakht

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of cardiovascular and thoracic research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. The Efficacy and Safety ofActa medica Philippina · 2023
    Article
  6. The immunomodulatory role ofFrontiers in pharmacology · 2023
    Review
  7. Aqueous Extract ofFoods (Basel, Switzerland) · 2022
    Article
  8. Article
  9. A Randomized, Triple-Blind, Placebo-Controlled, Add-On Clinical Trial to Evaluate the Efficacy ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Fataneh Hashem-DabaghianResearch Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mojtaba ZiaeeCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0002-9725-3033
Samad GhaffariCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Farzaneh NabatiMedicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
Saeed KianbakhtMedicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
Academic Center for Education, Culture and Research · IRTabriz University of Medical Sciences · IRIran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmlaCardiovascular DiseaseEmblica officinalisPharmacologyPhyllanthus emblica

Identifiers

PMID30386531
PMCPMC6203864
OpenAlexW2897227944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.